Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
50,986,486
-
Share change
-
+3,482,349
-
Total reported value
-
$799,217,264
-
Put/Call ratio
-
7.9%
-
Price per share
-
$15.68
-
Number of holders
-
165
-
Value change
-
+$55,391,133
-
Number of buys
-
89
-
Number of sells
-
68
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2015
As of 31 Mar 2015,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,986,486 shares.
The largest 10 holders included
FMR LLC, WASATCH ADVISORS INC, BlackRock Fund Advisors, STATE STREET CORP, VANGUARD GROUP INC, FRONTIER CAPITAL MANAGEMENT CO LLC, BlackRock Institutional Trust Company, N.A., Bank of New York Mellon Corp, JANUS CAPITAL MANAGEMENT LLC, and JENNISON ASSOCIATES LLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.